Product liability claims and vaccines
Contenido multimedia no disponible por derechos de autor o por acceso restringido. Contacte con la institución para más información.
| Tag | 1 | 2 | Valor |
|---|---|---|---|
| LDR | 00000cab a2200000 4500 | ||
| 001 | MAP20200032199 | ||
| 003 | MAP | ||
| 005 | 20201013170251.0 | ||
| 008 | 201009e20201001sgp|||p |0|||b|eng d | ||
| 040 | $aMAP$bspa$dMAP | ||
| 084 | $a335 | ||
| 100 | 1 | $0MAPA20170000556$aKhanna, Anoop | |
| 245 | 1 | 0 | $aProduct liability claims and vaccines$cAnoop Khanna |
| 520 | $aThe COVID-19 pandemic rages on, spurring global efforts to develop vaccines to curb it. However, who is liable for claims for damages in case of any side-effects of the vaccines that are being developed on a fast track, is the million-dollar question. | ||
| 650 | 4 | $0MAPA20080630454$aResponsabilidad civil de productos | |
| 650 | 4 | $0MAPA20080567118$aReclamaciones | |
| 650 | 4 | $0MAPA20200005599$aCOVID-19 | |
| 650 | 4 | $0MAPA20080552022$aPandemias | |
| 650 | 4 | $0MAPA20080575342$aDaños y perjuicios | |
| 650 | 4 | $0MAPA20080634865$aSeguro de responsabilidad civil de productos | |
| 650 | 4 | $0MAPA20080586294$aMercado de seguros | |
| 773 | 0 | $wMAP20090003767$tAsia insurance review$dSingapore : Ins Communications Pte Ltd., 2009-$x0218-2696$g01/10/2020 Número 10 - octubre 2020 , p. 14-15 |